SCOPUS BIOPHARMA INC.

Profile

Company Names

SCOPUS BIOPHARMA INC.

Addresses

420 LEXINGTON AVE., SUITE 300, NEW YORK, NY 10170

5 PENN PLAZA, 23RD FLOOR, NEW YORK, NY 10005

420 LEXINGTON AVENUE, SUITE 300, NEW YORK, NY 10170

Phone Numbers

212-479-2513
2124792513
(917) 674-3889

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$17,435,059.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2021-11-23 
$9,750,000.00 
$9,750,000.00 
$0.00 
Equity 
4
2020-06-10 
$6,346,322.00 
$6,346,322.00 
$0.00 
Equity 
3
2020-02-24 
$636,230.00 
$636,230.00 
$0.00 
Debt 
2
2019-12-23 
$252,000.00 
$500,000.00 
$248,000.00 
 
1
2019-07-25 
$450,507.00 
$600,000.00 
$149,493.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID 
S. 
BATTLEMAN 
DIRECTOR
SCOPUS BIOPHARMA INC.
DAVID 
A. 
BUCKEL 
DIRECTOR
SHARPSPRING, INC.   |  SCOPUS BIOPHARMA INC.
ROBERT 
J. 
GIBSON 
EXECUTIVE OFFICER, DIRECTOR
SCOPUS BIOPHARMA INC.   |  DUET BIOTHERAPEUTICS INC.
IRA 
SCOTT 
GREENSPAN 
DIRECTOR, EXECUTIVE OFFICER
PAVMED INC.   |  SCOPUS BIOPHARMA INC.   |  DUET BIOTHERAPEUTICS INC.
RAPHAEL 
 
HOFSTEIN 
DIRECTOR
TRIPHASE ACCELERATOR G.P. CORP   |  BIOLINERX LTD.   |  SCOPUS BIOPHARMA INC.   |  DUET BIOTHERAPEUTICS INC.
PAUL 
 
HOPPER 
EXECUTIVE OFFICER, DIRECTOR
FIBROCELL SCIENCE, INC.   |  SCOPUS BIOPHARMA INC.
PAUL 
E. 
HOPPER 
DIRECTOR
SCOPUS BIOPHARMA INC.
PAUL 
J. 
HOPPER 
EXECUTIVE OFFICER, DIRECTOR
SCOPUS BIOPHARMA INC.
JOSHUA 
 
LAMSTEIN 
EXECUTIVE OFFICER, DIRECTOR
TRADE SERVICE HOLDINGS, INC.   |  GROWTH + EMERGING MARKETS, LLC   |  FEED MEDIA INC.   |  KODEM THETARAY GROWTH L.P.   |  SCOPUS BIOPHARMA INC.   |  DUET BIOTHERAPEUTICS INC.   |  VALID INC.
JOSHUA 
R. 
LAMSTEIN 
EXECUTIVE OFFICER, DIRECTOR
PAVMED INC.   |  SCOPUS BIOPHARMA INC.
MORRIS 
C. 
LASTER 
EXECUTIVE OFFICER, DIRECTOR
SCOPUS BIOPHARMA INC.
ASHISH 
P. 
SANGHRAJKA 
EXECUTIVE OFFICER, DIRECTOR
SCOPUS BIOPHARMA INC.
DAVID 
 
WEILD 
DIRECTOR
BIOSIG TECHNOLOGIES, INC.   |  SCOPUS BIOPHARMA INC.   |  HIGH ROLLER TECHNOLOGIES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-12-07
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-11-23 
2020-07-10
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
 
2019-12-23 
2020-07-10
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Debt 
2019-12-23 
2020-07-10
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Debt 
2020-02-24 
2020-07-10
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2020-06-10 
2019-08-08
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2019-07-25 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
H.C. WAINWRIGHT + CO. LLC
375
NONE
NONE
HCFP/CAPITAL MARKETS LLC
149111